LifePoint Health Goes Private with Apollo Global Management

LifePoint Health Goes Private with Apollo Global Management

More for-profit hospitals are landing in the hands of private equity firms. On July 23, LifePoint Health, Inc. (NASDAQ: LPNT) announced its acquisition by private equity firm Apollo Global Management (NYSE: APO) for $5.6 billion. It will be merged with Apollo’s portfolio company, RCCH HealthCare Partners. The deal takes LifePoint Health private, although the combined company will operate under the LifePoint Health name and will be led by LifePoint’s current chairman and CEO, William F. Carpenter III. The combined company will have 84 non-urban hospitals in 30 states, pro forma 2017 revenues of more than $8 billion, as well as 7,000 affiliated physicians, approximately 60,000... Read More »
Dermatology Practice Deals Up 46% in 2017

Dermatology Practice Deals Up 46% in 2017

Acquisitions of dermatology practices are surging in 2017. Through mid-November, we’ve counted 37 transactions for these physician practices, up nearly 46% compared with all of 2016 (26 announced transactions), according to our Deal Search Online database. As we’ve noted before, private equity play a significant role in the increased deal count. Epiphany Dermatology, a portfolio company of CI Capital Partners, has been the busiest acquirer this year, with eight transactions concentrated in Arizona, New Mexico, Oklahoma and Texas. All had three or fewer physicians, and none of the deals disclosed prices. Two privately held companies have announced five transactions apiece in... Read More »

PE Firms Team Up to Buy CROs

The contract research organization (CRO) industry continues to consolidate at a rapid pace in response to growing demand from pharmaceutical and biotechnology companies. But pharma and biotech serve as the customers in this industry, not the acquirers. Nearly all the buyers in 2017 are other CRO companies that are seeking scale. Private equity is also joining the party, accounting for the remaining portion of deals, including the largest disclosed deal this year. Last month, INC Research Holdings (NASDAQ: INCR) paid $4.6 billion for inVentiv Health, a CRO that also counts Advent International and Thomas H. Lee Partners as equal equity holders. The firms will retain their stakes following... Read More »

PE Firms Flock to Dermatology Deals

Dermatology practices remain high on the list of healthcare sectors for private equity investors. Through mid-March, 2017, 12 deals targeting these practices have been announced by eight acquirers. All those acquirers are either private equity firms, or portfolio companies. Thanks to the private nature of these transactions, no financial terms have been publicly disclosed. Of the 17 dermatology deals announced in 2016, six acquirers were private equity firms and five were portfolio companies. Some big deals (even without disclosing prices) announced last year include Harvest Partners’ acquisition of Advanced Dermatology and Cosmetic Surgery from Audax Group, in May 2016. In October,... Read More »

Pharmacy Software Companies Merge

Specialty pharmacies have attracted a lot of interest from private equity firms in 2016. Now it’s specialty pharmacy services companies that are beginning to see consolidation. In October, Rx30, a portfolio company of GTCR since June 2015, merged with another pharmacy software supplier, privately held Computer Rx. Rx30 develops and supplies pharmacy management software solutions to the independent, hospital, long-term care and specialty pharmacy markets. Computer Rx has a similar focus, which includes community pharmacies. Rx30’s CEO Steve Wubker will lead the combined business. Roger Warkentine, founder of Computer Rx, will continue as an advisor to the combined business, and... Read More »